BilT03: Phase 1b/2 Multicenter Trial of Nivolumab with 5-Fluorouracil and Liposomal Irinotecan for Previously Treated Advanced Biliary Tract Cancer
Med（2024）
关键词
biliary cancer,cholangiocarcinoma,anti-PD-1 antibody,nivolumab,liposomal irinotecan
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要